GB0425196D0 - Gastrin and cholecystokinin receptor ligands - Google Patents

Gastrin and cholecystokinin receptor ligands

Info

Publication number
GB0425196D0
GB0425196D0 GB0425196A GB0425196A GB0425196D0 GB 0425196 D0 GB0425196 D0 GB 0425196D0 GB 0425196 A GB0425196 A GB 0425196A GB 0425196 A GB0425196 A GB 0425196A GB 0425196 D0 GB0425196 D0 GB 0425196D0
Authority
GB
United Kingdom
Prior art keywords
gastrin
receptor ligands
cholecystokinin receptor
cholecystokinin
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0425196A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
James Black Foundation Ltd
Original Assignee
James Black Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James Black Foundation Ltd filed Critical James Black Foundation Ltd
Priority to GB0425196A priority Critical patent/GB0425196D0/en
Publication of GB0425196D0 publication Critical patent/GB0425196D0/en
Priority to PCT/GB2005/004359 priority patent/WO2006051312A1/en
Priority to GB0711660A priority patent/GB2435190A/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
GB0425196A 2004-11-15 2004-11-15 Gastrin and cholecystokinin receptor ligands Ceased GB0425196D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0425196A GB0425196D0 (en) 2004-11-15 2004-11-15 Gastrin and cholecystokinin receptor ligands
PCT/GB2005/004359 WO2006051312A1 (en) 2004-11-15 2005-11-14 Gastrin and cholecystokinin receptor ligands
GB0711660A GB2435190A (en) 2004-11-15 2007-06-15 Gastrin and cholecystokinin receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425196A GB0425196D0 (en) 2004-11-15 2004-11-15 Gastrin and cholecystokinin receptor ligands

Publications (1)

Publication Number Publication Date
GB0425196D0 true GB0425196D0 (en) 2004-12-15

Family

ID=33523766

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0425196A Ceased GB0425196D0 (en) 2004-11-15 2004-11-15 Gastrin and cholecystokinin receptor ligands
GB0711660A Withdrawn GB2435190A (en) 2004-11-15 2007-06-15 Gastrin and cholecystokinin receptor ligands

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0711660A Withdrawn GB2435190A (en) 2004-11-15 2007-06-15 Gastrin and cholecystokinin receptor ligands

Country Status (2)

Country Link
GB (2) GB0425196D0 (en)
WO (1) WO2006051312A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014026997A1 (en) 2012-08-16 2014-02-20 Bayer Pharma Aktiengesellschaft 2,3-benzodiazepines
MA38346B1 (en) 2013-02-19 2019-05-31 Bayer Pharma AG 2,3-benzodiazepines bicyclo- and spirocyclosubstituted
WO2014128111A1 (en) 2013-02-22 2014-08-28 Bayer Pharma Aktiengesellschaft 4-substituted pyrrolo- and pyrazolo-diazepines
CA2901799A1 (en) 2013-02-22 2014-08-28 Bayer Pharma Aktiengesellschaft Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
JP6502939B2 (en) 2013-11-22 2019-04-17 シーエル バイオサイエンシズ リミティド ライアビリティ カンパニー Gastrin antagonists for the treatment and prevention of osteoporosis
WO2015121226A1 (en) * 2014-02-13 2015-08-20 Bayer Pharma Aktiengesellschaft 6-substituted 2,3-benzodiazepines
WO2017005711A1 (en) * 2015-07-09 2017-01-12 Bayer Pharma Aktiengesellschaft Phosphorous-and sulfur-substituted benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
ATE293449T1 (en) * 2001-11-13 2005-05-15 Black James Foundation BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS
US7524837B2 (en) * 2003-05-12 2009-04-28 Janssen Pharmaceutica N.V. Benzotriazapinone salts and methods for using same

Also Published As

Publication number Publication date
GB0711660D0 (en) 2007-07-25
WO2006051312A1 (en) 2006-05-18
GB2435190A (en) 2007-08-15

Similar Documents

Publication Publication Date Title
HK1107763A1 (en) Crth2 receptor ligands for medicinal uses
HK1155726A1 (en) Opioid receptor modulators
GB0400440D0 (en) Receptor modulators
EP1898962A4 (en) Gastrin releasing peptide compounds
GB0711660D0 (en) Gastrin and cholecystokinin receptor ligands
HK1089446A1 (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
EP1601641A4 (en) Substituted anilide ligands for the thyroid receptor
IL161330A0 (en) Benzotriazepines as gastrin and cholecystokinin receptor ligands
GB0310865D0 (en) Gastrin and cholecystokinin receptor ligands
IL173337A0 (en) Receptor
HK1088794A1 (en) A pad and clothes using the pad
GB0310864D0 (en) Gastrin and cholecystokinin receptor ligands
GB0414798D0 (en) Receptor
SI1648899T1 (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
GB0413872D0 (en) Receptor
GB0416592D0 (en) Mat
GB0321998D0 (en) Receptor
GB0404309D0 (en) Receptor
GB0423327D0 (en) Receptor
GB0413096D0 (en) Receptor
GB0404584D0 (en) Receptor
GB0417119D0 (en) Receptor
GB0427025D0 (en) Receptor
GB0211204D0 (en) Receptor and its ligand
GB0211205D0 (en) Receptor and ligand

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)